بدائل البحث:
patient decrease » point decrease (توسيع البحث), transient decrease (توسيع البحث), largest decrease (توسيع البحث)
teer decrease » mean decrease (توسيع البحث), greater decrease (توسيع البحث)
step decrease » sizes decrease (توسيع البحث), we decrease (توسيع البحث)
a decrease » _ decrease (توسيع البحث), _ decreased (توسيع البحث), _ decreases (توسيع البحث)
_ patient » _ patients (توسيع البحث)
يعرض 1 - 20 نتائج من 7,658 نتيجة بحث عن '(( third ((((teer decrease) OR (a decrease))) OR (step decrease)) ) OR ( _ patient decrease ))', وقت الاستعلام: 0.68s تنقيح النتائج
  1. 1
    Third.

    Third. حسب Cuicui Liu (1496260)

    منشور في 2024
    أضف إلى المفضلة
    محفوظ في:
  2. 2
    These subfigures show a visualization of the context embeddings for the DSVAE model with LS=2=4,CS=2. The first subfigure from the left shows three patient clusters, the second subfigure both patients and controls, the third colors context embeddings based on the subject’s age, and the last subfigure colors the context embeddings based on the subject’s cognitive score, CMINDs.

    These subfigures show a visualization of the context embeddings for the DSVAE model with LS=2=4,CS=2. The first subfigure from the left shows three patient clusters, the second sub... حسب Eloy Geenjaar (21533195)

    منشور في 2025
    الموضوعات:
    أضف إلى المفضلة
    محفوظ في:
  3. 3
    Maximum IFN concentrations are decreased in severe patients.

    Maximum IFN concentrations are decreased in severe patients. حسب Sonia T. Gazeau (21512764)

    منشور في 2025
    أضف إلى المفضلة
    محفوظ في:
  4. 4
    Flow diagram of patient selection for the study.

    Flow diagram of patient selection for the study. حسب Yusuke Fuchioka (22806178)

    منشور في 2025
    الموضوعات:
    أضف إلى المفضلة
    محفوظ في:
  5. 5
    Experimental validation revealed that ACADSB and ACADM decreased in patients with UC.

    Experimental validation revealed that ACADSB and ACADM decreased in patients with UC. حسب Hongliang Chen (538815)

    منشور في 2025
    أضف إلى المفضلة
    محفوظ في:
  6. 6
    Additional file 7 of Decreased complement 4 and interleukin-10 as biomarkers in aqueous humour for non-exudative age-related macular degeneration: a case control study

    Additional file 7 of Decreased complement 4 and interleukin-10 as biomarkers in aqueous humour for non-exudative age-related macular degeneration: a case control study حسب Juliane Schikora (20871169)

    منشور في 2025
    أضف إلى المفضلة
    محفوظ في:
  7. 7
    Additional file 3 of Decreased complement 4 and interleukin-10 as biomarkers in aqueous humour for non-exudative age-related macular degeneration: a case control study

    Additional file 3 of Decreased complement 4 and interleukin-10 as biomarkers in aqueous humour for non-exudative age-related macular degeneration: a case control study حسب Juliane Schikora (20871169)

    منشور في 2025
    أضف إلى المفضلة
    محفوظ في:
  8. 8
    Dynamic Covalent Chemistry Enabled Closed-Loop Recycling of Thermally Modified Polymer Membrane

    Dynamic Covalent Chemistry Enabled Closed-Loop Recycling of Thermally Modified Polymer Membrane حسب Ching Yoong Loh (17863097)

    منشور في 2025
    الموضوعات:
    أضف إلى المفضلة
    محفوظ في:
  9. 9
    Dynamic Covalent Chemistry Enabled Closed-Loop Recycling of Thermally Modified Polymer Membrane

    Dynamic Covalent Chemistry Enabled Closed-Loop Recycling of Thermally Modified Polymer Membrane حسب Ching Yoong Loh (17863097)

    منشور في 2025
    الموضوعات:
    أضف إلى المفضلة
    محفوظ في:
  10. 10
    Dynamic Covalent Chemistry Enabled Closed-Loop Recycling of Thermally Modified Polymer Membrane

    Dynamic Covalent Chemistry Enabled Closed-Loop Recycling of Thermally Modified Polymer Membrane حسب Ching Yoong Loh (17863097)

    منشور في 2025
    الموضوعات:
    أضف إلى المفضلة
    محفوظ في:
  11. 11
    Dynamic Covalent Chemistry Enabled Closed-Loop Recycling of Thermally Modified Polymer Membrane

    Dynamic Covalent Chemistry Enabled Closed-Loop Recycling of Thermally Modified Polymer Membrane حسب Ching Yoong Loh (17863097)

    منشور في 2025
    الموضوعات:
    أضف إلى المفضلة
    محفوظ في:
  12. 12
    Dynamic Covalent Chemistry Enabled Closed-Loop Recycling of Thermally Modified Polymer Membrane

    Dynamic Covalent Chemistry Enabled Closed-Loop Recycling of Thermally Modified Polymer Membrane حسب Ching Yoong Loh (17863097)

    منشور في 2025
    الموضوعات:
    أضف إلى المفضلة
    محفوظ في:
  13. 13
    Table6_Use of non-specific immunoglobulins in Catalonia in three third-level hospitals: a descriptive analysis of a hospital-prescribed medication registry.docx

    Table6_Use of non-specific immunoglobulins in Catalonia in three third-level hospitals: a descriptive analysis of a hospital-prescribed medication registry.docx حسب J. Riera-Arnau (20431328)

    منشور في 2024
    "…In the sensitivity analysis, the A-level usage rate decreased to one-third and the B-level usage rate increased by 2–3 times. …"
    أضف إلى المفضلة
    محفوظ في:
  14. 14
    Table4_Use of non-specific immunoglobulins in Catalonia in three third-level hospitals: a descriptive analysis of a hospital-prescribed medication registry.docx

    Table4_Use of non-specific immunoglobulins in Catalonia in three third-level hospitals: a descriptive analysis of a hospital-prescribed medication registry.docx حسب J. Riera-Arnau (20431328)

    منشور في 2024
    "…In the sensitivity analysis, the A-level usage rate decreased to one-third and the B-level usage rate increased by 2–3 times. …"
    أضف إلى المفضلة
    محفوظ في:
  15. 15
    Table2_Use of non-specific immunoglobulins in Catalonia in three third-level hospitals: a descriptive analysis of a hospital-prescribed medication registry.docx

    Table2_Use of non-specific immunoglobulins in Catalonia in three third-level hospitals: a descriptive analysis of a hospital-prescribed medication registry.docx حسب J. Riera-Arnau (20431328)

    منشور في 2024
    "…In the sensitivity analysis, the A-level usage rate decreased to one-third and the B-level usage rate increased by 2–3 times. …"
    أضف إلى المفضلة
    محفوظ في:
  16. 16
    Table8_Use of non-specific immunoglobulins in Catalonia in three third-level hospitals: a descriptive analysis of a hospital-prescribed medication registry.docx

    Table8_Use of non-specific immunoglobulins in Catalonia in three third-level hospitals: a descriptive analysis of a hospital-prescribed medication registry.docx حسب J. Riera-Arnau (20431328)

    منشور في 2024
    "…In the sensitivity analysis, the A-level usage rate decreased to one-third and the B-level usage rate increased by 2–3 times. …"
    أضف إلى المفضلة
    محفوظ في:
  17. 17
    Table5_Use of non-specific immunoglobulins in Catalonia in three third-level hospitals: a descriptive analysis of a hospital-prescribed medication registry.docx

    Table5_Use of non-specific immunoglobulins in Catalonia in three third-level hospitals: a descriptive analysis of a hospital-prescribed medication registry.docx حسب J. Riera-Arnau (20431328)

    منشور في 2024
    "…In the sensitivity analysis, the A-level usage rate decreased to one-third and the B-level usage rate increased by 2–3 times. …"
    أضف إلى المفضلة
    محفوظ في:
  18. 18
    Table3_Use of non-specific immunoglobulins in Catalonia in three third-level hospitals: a descriptive analysis of a hospital-prescribed medication registry.docx

    Table3_Use of non-specific immunoglobulins in Catalonia in three third-level hospitals: a descriptive analysis of a hospital-prescribed medication registry.docx حسب J. Riera-Arnau (20431328)

    منشور في 2024
    "…In the sensitivity analysis, the A-level usage rate decreased to one-third and the B-level usage rate increased by 2–3 times. …"
    أضف إلى المفضلة
    محفوظ في:
  19. 19
    Table7_Use of non-specific immunoglobulins in Catalonia in three third-level hospitals: a descriptive analysis of a hospital-prescribed medication registry.docx

    Table7_Use of non-specific immunoglobulins in Catalonia in three third-level hospitals: a descriptive analysis of a hospital-prescribed medication registry.docx حسب J. Riera-Arnau (20431328)

    منشور في 2024
    "…In the sensitivity analysis, the A-level usage rate decreased to one-third and the B-level usage rate increased by 2–3 times. …"
    أضف إلى المفضلة
    محفوظ في:
  20. 20
    Table1_Use of non-specific immunoglobulins in Catalonia in three third-level hospitals: a descriptive analysis of a hospital-prescribed medication registry.DOCX

    Table1_Use of non-specific immunoglobulins in Catalonia in three third-level hospitals: a descriptive analysis of a hospital-prescribed medication registry.DOCX حسب J. Riera-Arnau (20431328)

    منشور في 2024
    "…In the sensitivity analysis, the A-level usage rate decreased to one-third and the B-level usage rate increased by 2–3 times. …"
    أضف إلى المفضلة
    محفوظ في:

أدوات البحث: